Mickel J. Hansen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mickel J. Hansen has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Ben Lucas Feringa
Stratingh Institute for Chemistry, University of Groningen, Nijenborgh 3, 9747 AG Groningen, the Netherlands
7 shared publications - Wiktor Szymanski
Department of Medicinal Chemistry Photopharmacology and Imaging Groningen Research Institute of Pharmacy University of Groningen Groningen the Netherlands
7 shared publications - Michael Markus Lerch
Stratingh Institute for Chemistry, University of Groningen, Nijenborgh 7, 9747 AG, Groningen, The Netherlands
4 shared publications - Denis Jacquemin
Nantes Université CNRS, CEISAM – UMR 6230 Nantes France
2 shared publications - Gooitzen Michell van Dam
Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
2 shared publications - Lucien Nathanaël Lameijer
Medical Imaging Center University Medical Center Groningen University of Groningen Hanzeplein 1 9713GZ Groningen The Netherlands
2 shared publications
Latest Publications
- Open Access
- 17 August 2020
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 59 (48) , 21663-21670
General Principles for the Design of Visible‐Light‐Responsive Photoswitches: Tetra‐ortho‐Chloro‐Azobenzenes
Molecular photoswitches enable reversible external control of biological systems, nanomachines, and smart materials. Their development is driven by the need for low energy (green‐red‐NIR) light switching, to allow non‐invasive operation with deep tissue penetration. The lack of clear design principles for the adaptation and optimization of such systems limits further applications. Here we provide a design rulebook for tetra‐ortho‐chloroazobenzenes, an emerging class of visible‐light‐responsive photochromes, by elucidating the role that substituents play in defining their key characteristics: absorption spectra, band overlap, photoswitching efficiencies, and half‐lives of the unstable cis isomers. This is achieved through joint photochemical and theoretical analyses of a representative library of molecules featuring substituents of varying electronic nature. A set of guidelines is presented that enables tuning of properties to the desired application through informed photochrome engineering.
- 17 August 2020
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 59 (48) , 21663-21670
Open AccessGeneral Principles for the Design of Visible‐Light‐Responsive Photoswitches: Tetra‐ortho‐Chloro‐Azobenzenes
Molecular photoswitches enable reversible external control of biological systems, nanomachines, and smart materials. Their development is driven by the need for low energy (green‐red‐NIR) light switching, to allow non‐invasive operation with deep tissue penetration. The lack of clear design principles for the adaptation and optimization of such systems limits further applications. Here we provide a design rulebook for tetra‐ortho‐chloroazobenzenes, an emerging class of visible‐light‐responsive photochromes, by elucidating the role that substituents play in defining their key characteristics: absorption spectra, band overlap, photoswitching efficiencies, and half‐lives of the unstable cis isomers. This is achieved through joint photochemical and theoretical analyses of a representative library of molecules featuring substituents of varying electronic nature. A set of guidelines is presented that enables tuning of properties to the desired application through informed photochrome engineering.
- Open Access
- 17 August 2020
- Published by Wiley in Angewandte Chemie
- Vol. 132 (48) , 21847-21854
General Principles for the Design of Visible‐Light‐Responsive Photoswitches: Tetra‐ortho‐Chloro‐Azobenzenes
Molecular photoswitches enable reversible external control of biological systems, nanomachines, and smart materials. Their development is driven by the need for low energy (green‐red‐NIR) light switching, to allow non‐invasive operation with deep tissue penetration. The lack of clear design principles for the adaptation and optimization of such systems limits further applications. Here we provide a design rulebook for tetra‐ortho‐chloroazobenzenes, an emerging class of visible‐light‐responsive photochromes, by elucidating the role that substituents play in defining their key characteristics: absorption spectra, band overlap, photoswitching efficiencies, and half‐lives of the unstable cis isomers. This is achieved through joint photochemical and theoretical analyses of a representative library of molecules featuring substituents of varying electronic nature. A set of guidelines is presented that enables tuning of properties to the desired application through informed photochrome engineering.
- 17 August 2020
- Published by Wiley in Angewandte Chemie
- Vol. 132 (48) , 21847-21854
Open AccessGeneral Principles for the Design of Visible‐Light‐Responsive Photoswitches: Tetra‐ortho‐Chloro‐Azobenzenes
Molecular photoswitches enable reversible external control of biological systems, nanomachines, and smart materials. Their development is driven by the need for low energy (green‐red‐NIR) light switching, to allow non‐invasive operation with deep tissue penetration. The lack of clear design principles for the adaptation and optimization of such systems limits further applications. Here we provide a design rulebook for tetra‐ortho‐chloroazobenzenes, an emerging class of visible‐light‐responsive photochromes, by elucidating the role that substituents play in defining their key characteristics: absorption spectra, band overlap, photoswitching efficiencies, and half‐lives of the unstable cis isomers. This is achieved through joint photochemical and theoretical analyses of a representative library of molecules featuring substituents of varying electronic nature. A set of guidelines is presented that enables tuning of properties to the desired application through informed photochrome engineering.
- 26 September 2016
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 55 (43) , 13514-13518
Direct and Versatile Synthesis of Red‐Shifted Azobenzenes
A straightforward synthesis of azobenzenes with bathochromically‐shifted absorption bands is presented. It employs an ortho‐lithiation of aromatic substrates, followed by a coupling reaction with aryldiazonium salts. The products are obtained with good to excellent yields after simple purification. Moreover, with the presented methodology, a structurally diverse panel of different azobenzenes, including unsymmetric tetra‐ortho‐substituted ones, can be readily obtained, which paves the way for future development of red‐light‐addressable azobenzene derivatives for in vivo application.
- 26 September 2016
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 55 (43) , 13514-13518
Direct and Versatile Synthesis of Red‐Shifted Azobenzenes
A straightforward synthesis of azobenzenes with bathochromically‐shifted absorption bands is presented. It employs an ortho‐lithiation of aromatic substrates, followed by a coupling reaction with aryldiazonium salts. The products are obtained with good to excellent yields after simple purification. Moreover, with the presented methodology, a structurally diverse panel of different azobenzenes, including unsymmetric tetra‐ortho‐substituted ones, can be readily obtained, which paves the way for future development of red‐light‐addressable azobenzene derivatives for in vivo application.
- 26 September 2016
- Published by Wiley in Angewandte Chemie
- Vol. 128 (43) , 13712-13716
Direct and Versatile Synthesis of Red‐Shifted Azobenzenes
A straightforward synthesis of azobenzenes with bathochromically‐shifted absorption bands is presented. It employs an ortho‐lithiation of aromatic substrates, followed by a coupling reaction with aryldiazonium salts. The products are obtained with good to excellent yields after simple purification. Moreover, with the presented methodology, a structurally diverse panel of different azobenzenes, including unsymmetric tetra‐ortho‐substituted ones, can be readily obtained, which paves the way for future development of red‐light‐addressable azobenzene derivatives for in vivo application.
- 26 September 2016
- Published by Wiley in Angewandte Chemie
- Vol. 128 (43) , 13712-13716
Direct and Versatile Synthesis of Red‐Shifted Azobenzenes
A straightforward synthesis of azobenzenes with bathochromically‐shifted absorption bands is presented. It employs an ortho‐lithiation of aromatic substrates, followed by a coupling reaction with aryldiazonium salts. The products are obtained with good to excellent yields after simple purification. Moreover, with the presented methodology, a structurally diverse panel of different azobenzenes, including unsymmetric tetra‐ortho‐substituted ones, can be readily obtained, which paves the way for future development of red‐light‐addressable azobenzene derivatives for in vivo application.
- 4 July 2016
- Published by Wiley in Angewandte Chemie
- Vol. 128 (37) , 11140-11163
Neue Ziele für die Photopharmakologie
Das Feld der Photopharmakologie nutzt durch Licht schaltbare Moleküle, um Kontrolle über die Wirkung biologisch aktiver Verbindungen zu erlangen. Das Ziel ist es, die systemische Toxizität von Wirkstoffen wie auch die Herausbildung von Resistenzen zu vermindern und gleichzeitig eine extrem hohe Präzision in der Behandlung zu erreichen. Durch die Verwendung niedermolekularer Verbindungen stellt die Photopharmakologie eine valide Alternative zur Optogenetik dar. Wir präsentieren hier einen Überblick über die pharmakologischen Zielstrukturen in verschiedenen Organen sowie über Organsysteme im menschlichen Körper, die auf nicht‐invasive Weise angesteuert werden können. Wir diskutieren die Perspektiven einer selektiven Lichtzuführung zu diesen Organen sowie die spezifischen Anforderungen lichtaktivierbarer Wirkstoffe. Über anwendungsorientierte Aspekte hinaus sind wir bestrebt, die Wirkstofftauglichkeit (“druggability”) pharmazeutischer Zielstrukturen anhand aktueller Ergebnisse zu illustrieren. Ferner wollen wir aufzeigen, an welchen Stellen neue Ansätze erforscht werden müssen, damit die Umsetzung von “intelligentem” Moleküldesign in der Photopharmakologie zur klinischen Anwendung gelingt.
- 4 July 2016
- Published by Wiley in Angewandte Chemie
- Vol. 128 (37) , 11140-11163
Neue Ziele für die Photopharmakologie
Das Feld der Photopharmakologie nutzt durch Licht schaltbare Moleküle, um Kontrolle über die Wirkung biologisch aktiver Verbindungen zu erlangen. Das Ziel ist es, die systemische Toxizität von Wirkstoffen wie auch die Herausbildung von Resistenzen zu vermindern und gleichzeitig eine extrem hohe Präzision in der Behandlung zu erreichen. Durch die Verwendung niedermolekularer Verbindungen stellt die Photopharmakologie eine valide Alternative zur Optogenetik dar. Wir präsentieren hier einen Überblick über die pharmakologischen Zielstrukturen in verschiedenen Organen sowie über Organsysteme im menschlichen Körper, die auf nicht‐invasive Weise angesteuert werden können. Wir diskutieren die Perspektiven einer selektiven Lichtzuführung zu diesen Organen sowie die spezifischen Anforderungen lichtaktivierbarer Wirkstoffe. Über anwendungsorientierte Aspekte hinaus sind wir bestrebt, die Wirkstofftauglichkeit (“druggability”) pharmazeutischer Zielstrukturen anhand aktueller Ergebnisse zu illustrieren. Ferner wollen wir aufzeigen, an welchen Stellen neue Ansätze erforscht werden müssen, damit die Umsetzung von “intelligentem” Moleküldesign in der Photopharmakologie zur klinischen Anwendung gelingt.
- Top Cited Papers
- 4 July 2016
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 55 (37) , 10978-10999
Emerging Targets in Photopharmacology
The field of photopharmacology uses molecular photoswitches to establish control over the action of bioactive molecules. It aims to reduce systemic drug toxicity and the emergence of resistance, while achieving unprecedented precision in treatment. By using small molecules, photopharmacology provides a viable alternative to optogenetics. We present here a critical overview of the different pharmacological targets in various organs and a survey of organ systems in the human body that can be addressed in a non‐invasive manner. We discuss the prospects for the selective delivery of light to these organs and the specific requirements for light‐activatable drugs. We also aim to illustrate the druggability of medicinal targets with recent findings and emphasize where conceptually new approaches have to be explored to provide photopharmacology with future opportunities to bring “smart” molecular design ultimately to the realm of clinical use.
- 4 July 2016
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 55 (37) , 10978-10999
Top Cited PapersEmerging Targets in Photopharmacology
The field of photopharmacology uses molecular photoswitches to establish control over the action of bioactive molecules. It aims to reduce systemic drug toxicity and the emergence of resistance, while achieving unprecedented precision in treatment. By using small molecules, photopharmacology provides a viable alternative to optogenetics. We present here a critical overview of the different pharmacological targets in various organs and a survey of organ systems in the human body that can be addressed in a non‐invasive manner. We discuss the prospects for the selective delivery of light to these organs and the specific requirements for light‐activatable drugs. We also aim to illustrate the druggability of medicinal targets with recent findings and emphasize where conceptually new approaches have to be explored to provide photopharmacology with future opportunities to bring “smart” molecular design ultimately to the realm of clinical use.
- Open Access
- 12 September 2014
- Published by Wiley in ChemBioChem
- Vol. 15 (14) , 2009
Cover Picture: Proteasome Inhibitors with Photocontrolled Activity (ChemBioChem 14/2014)
- 12 September 2014
- Published by Wiley in ChemBioChem
- Vol. 15 (14) , 2009
Open AccessCover Picture: Proteasome Inhibitors with Photocontrolled Activity (ChemBioChem 14/2014)